<p>Biomarkers in acute myocardial infarction: current perspectives</p>
Fırat University · Sağlık Bilimleri Üniversitesi · +2 more institutions
Abstract
The present study was carried out using meta-analyses, reviews of clinical trials, evidence-based medicine, and guidelines indexed in PubMed and Web of Science.
These numerous AMI biomarkers guide clinical applications (diagnostic methods, risk stratification, and treatment). Today, however, TnI remains the gold standard for the diagnosis of AMI. Details in the text will be given of many biomarkers for the diagnosis of AMI.
Citation impact
- FWCI
- 31.46
- Percentile
- 100%
- References
- 83
Authors
5- SASüleyman AydınCorresponding
Fırat University, Sağlık Bilimleri Üniversitesi, Elazığ Eğitim ve Araştırma Hastanesi
- KUKader Uğur
Fırat University
- SASuna Aydın
Fırat University, Sağlık Bilimleri Üniversitesi, Elazığ Eğitim ve Araştırma Hastanesi
- İŞİbrahim Şahin
Fırat University, Erzincan Binali Yıldırım University
- MYMeltem Yardım
Fırat University
Topics & keywords
- Medicine
- Myocardial infarction
- Procalcitonin
- Intensive care medicine
- Biomarker
- Chest pain
- Internal medicine
- Sepsis
- Good health and well-being